Selenium Coated Dialysis Catheters for Reduced Biofilm Formation
用于减少生物膜形成的硒涂层透析导管
基本信息
- 批准号:7155346
- 负责人:
- 金额:$ 17.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-30 至 2007-12-31
- 项目状态:已结题
- 来源:
- 关键词:antibacterial agentsbacterial diseasebiofilmbiomaterial compatibilitybiomaterial evaluationbiomedical equipment developmentcatheterizationcell adhesionclinical biomedical equipmentcommunicable disease controlcovalent bondgrowth inhibitorshemodialysislaboratory mousemedical complicationseleniumsurface coatingtoxicology
项目摘要
DESCRIPTION (provided by applicant): Project Summary/Abstract: Infection is a major problem affecting function and longevity of dialysis catheters. Catheter-related sepsis occurs at alarmingly high rates, and often necessitates intervention or catheter removal. We propose to develop selenium-based coatings for dialysis catheters to prevent bacterial attachment and colonization that can ultimately lead to biofilm formation and device-centered infection. Selenium is an essential dietary requirement for humans. Selected selenium compounds are catalytic and produce superoxide radicals (O2) by their reaction with thiols. High local concentrations of these superoxides-cause lysis of bacterial cells, and could be particularly effective in preventing biofilm formation, since the mechanism of action for the superoxide does not require cells to be metabolically active. Selenium will be covalently attached to the surface of the catheters utilizing a unique combination of a plasma pre-treatment surface activation process (for both external and lumenal surfaces) followed by chemical attachment. Since it is catalytic, the covalently attached compound will remain on the surface and be active permanently, unlike conventional eluting coatings that are often gone within 30 days and that can elicit deleterious systemic effects. Since the superoxide radical has only a very short diffusion lifetime, the selenium coatings will be only locally active and will not adversely affect biocompatibility of the device with neighboring human cells. This grant will examine the hypothesis that a covalently attached selenium coating can reduce biofilm formation on the surface of dialysis catheters. In Phase I, efficacy of the coating will be evaluated in an in vitro bacterial flow cell model. Several surface concentrations of selenium will be examined to determine minimum required quantities and, ultimately, optimal levels. Baseline biocompatibility and toxicology tests will be conducted. Project Narrative: The proposed project would develop selenium coatings to reduce biofilm formation and device-centered infection on dialysis catheters. The coating would provide significant benefits to dialysis patients by preserving access and reducing secondary complications resulting from infected catheters. Due to the prevalence of the infection problem in dialysis catheters, an effective treatment could significantly impact cost of healthcare delivery for dialysis patients using catheters as their primary access.
描述(由申请人提供): 项目摘要/摘要:感染是影响透析导管功能和寿命的主要问题。导管相关脓毒症的发生率高得惊人,并且通常需要干预或拔除导管。我们建议开发用于透析导管的硒基涂层,以防止细菌附着和定殖,最终导致生物膜形成和以设备为中心的感染。硒是人类必需的饮食需求。选定的硒化合物具有催化作用,通过与硫醇反应产生超氧自由基 (O2)。这些超氧化物的高局部浓度会导致细菌细胞裂解,并且对于防止生物膜形成特别有效,因为超氧化物的作用机制不需要细胞具有代谢活性。利用等离子体预处理表面活化工艺(针对外表面和内腔表面)和化学附着的独特组合,将硒共价附着到导管表面。由于它具有催化作用,因此共价连接的化合物将保留在表面上并永久保持活性,这与传统的洗脱涂层不同,传统的洗脱涂层通常在 30 天内消失,并可能引起有害的全身效应。由于超氧自由基的扩散寿命非常短,因此硒涂层仅具有局部活性,不会对装置与邻近人体细胞的生物相容性产生不利影响。这笔资助将检验共价附着的硒涂层可以减少透析导管表面生物膜形成的假设。在第一阶段,将在体外细菌流动细胞模型中评估涂层的功效。将检查硒的几种表面浓度,以确定最低需求量,并最终确定最佳水平。将进行基线生物相容性和毒理学测试。项目叙述:拟议的项目将开发硒涂层,以减少透析导管上的生物膜形成和以设备为中心的感染。该涂层将为透析患者提供显着的益处,通过保留通道并减少受感染导管引起的继发并发症。由于透析导管中感染问题的普遍存在,有效的治疗可能会显着影响使用导管作为主要途径的透析患者的医疗服务成本。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC J TOBIN其他文献
ERIC J TOBIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC J TOBIN', 18)}}的其他基金
Selenium Coated Dialysis Catheters for Reduced Biofilm Formation
用于减少生物膜形成的硒涂层透析导管
- 批准号:
7537914 - 财政年份:2006
- 资助金额:
$ 17.62万 - 项目类别:
Selenium Coated Dialysis Catheters for Reduced Biofilm Formation
用于减少生物膜形成的硒涂层透析导管
- 批准号:
7664457 - 财政年份:2006
- 资助金额:
$ 17.62万 - 项目类别:
Functionally Graded HA Coatings for Biological Response
用于生物响应的功能分级 HA 涂层
- 批准号:
6742888 - 财政年份:2004
- 资助金额:
$ 17.62万 - 项目类别:
Efficacy of Thin HA Coating Produced by a Novel Process
采用新工艺生产的薄 HA 涂层的功效
- 批准号:
6337630 - 财政年份:2001
- 资助金额:
$ 17.62万 - 项目类别:
Efficacy of Thin HA Coatings Produced by a Novel Process
采用新工艺生产的薄 HA 涂层的功效
- 批准号:
6785676 - 财政年份:2001
- 资助金额:
$ 17.62万 - 项目类别:
Efficacy of Thin HA Coatings Produced by a Novel Process
采用新工艺生产的薄 HA 涂层的功效
- 批准号:
6882011 - 财政年份:2001
- 资助金额:
$ 17.62万 - 项目类别:
Nanocomposite Surface for Very Low Wear Orthopedics
用于极低磨损骨科的纳米复合材料表面
- 批准号:
6524028 - 财政年份:1999
- 资助金额:
$ 17.62万 - 项目类别:
Nanocomposite Surface for Very Low Wear Orthopedics
用于极低磨损骨科的纳米复合材料表面
- 批准号:
6403955 - 财政年份:1999
- 资助金额:
$ 17.62万 - 项目类别:
NANOCOMPOSITE SURFACE FOR VERY LOW WEAR ORTHOPEDICS
用于极低磨损骨科的纳米复合材料表面
- 批准号:
6015534 - 财政年份:1999
- 资助金额:
$ 17.62万 - 项目类别:
相似国自然基金
海南岛和西沙群岛周边海域石珊瑚细菌性疾病的研究
- 批准号:41066003
- 批准年份:2010
- 资助金额:27.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Treatment of periodontitis by epidermal growth factor receptor inhibitor
表皮生长因子受体抑制剂治疗牙周炎
- 批准号:
479002 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Operating Grants
Resolving Oral Bacteria Interactions with a High-Throughput Low-Cost Single-Cell Transcriptomics Approach
采用高通量低成本单细胞转录组学方法解决口腔细菌相互作用
- 批准号:
10678379 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Metabolic modulation of Fusobacterium nucleatum virulence
具核梭杆菌毒力的代谢调节
- 批准号:
10681729 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Regulatory mechanism of novel host-relevant biofilm formation protein in non-Cholera Vibrio species
非霍乱弧菌中新型宿主相关生物膜形成蛋白的调节机制
- 批准号:
10505474 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Nitric oxide-releasing hyaluronic acid therapeutics for treating periodontal disease
释放一氧化氮的透明质酸疗法用于治疗牙周病
- 批准号:
10657158 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别: